These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 11336660

  • 1. Human oestrogenic 17beta-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction.
    Gangloff A, Garneau A, Huang YW, Yang F, Lin SX.
    Biochem J; 2001 May 15; 356(Pt 1):269-76. PubMed ID: 11336660
    [Abstract] [Full Text] [Related]

  • 2. Human estrogenic 17beta-hydroxysteroid dehydrogenase: predominance of estrone reduction and its induction by NADPH.
    Jin JZ, Lin SX.
    Biochem Biophys Res Commun; 1999 Jun 07; 259(2):489-93. PubMed ID: 10362535
    [Abstract] [Full Text] [Related]

  • 3. Substrate inhibition of 17β-HSD1 in living cells and regulation of 17β-HSD7 by 17β-HSD1 knockdown.
    Han H, Thériault JF, Chen G, Lin SX.
    J Steroid Biochem Mol Biol; 2017 Sep 07; 172():36-45. PubMed ID: 28554725
    [Abstract] [Full Text] [Related]

  • 4. Crystal structures of human 17β-hydroxysteroid dehydrogenase type 1 complexed with estrone and NADP+ reveal the mechanism of substrate inhibition.
    Li T, Stephen P, Zhu DW, Shi R, Lin SX.
    FEBS J; 2019 Jun 07; 286(11):2155-2166. PubMed ID: 30768851
    [Abstract] [Full Text] [Related]

  • 5. The dual sex hormone specificity for human reductive 17β-hydroxysteroid dehydrogenase type 7: Synergistic function in estrogen and androgen control.
    Thériault JF, Lin SX.
    J Steroid Biochem Mol Biol; 2019 Feb 07; 186():61-65. PubMed ID: 30227243
    [Abstract] [Full Text] [Related]

  • 6. Regulation of human placental 17 beta-hydroxysteroid oxidoreductase: mechanism of stimulation of 17 beta-estradiol formation from estrone by 5 alpha-dihydrotestosterone in homogenates and villi in vitro.
    Blomquist CH, Hakanson EY.
    J Steroid Biochem Mol Biol; 1991 Nov 07; 39(5A):735-40. PubMed ID: 1659869
    [Abstract] [Full Text] [Related]

  • 7. New insights into the substrate inhibition of human 17β-hydroxysteroid dehydrogenase type 1.
    Li T, Song X, Stephen P, Yin H, Lin SX.
    J Steroid Biochem Mol Biol; 2023 Apr 07; 228():106246. PubMed ID: 36634828
    [Abstract] [Full Text] [Related]

  • 8. Characterisation of estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity in the human brain.
    Steckelbroeck S, Watzka M, Reissinger A, Wegener-Toper P, Bidlingmaier F, Bliesener N, Hans VH, Clusmann H, Ludwig M, Siekmann L, Klingmüller D.
    J Steroid Biochem Mol Biol; 2003 Jul 07; 86(1):79-92. PubMed ID: 12943747
    [Abstract] [Full Text] [Related]

  • 9. Studies on the activity of 17 beta-hydroxysteroid dehydrogenase in human adipose tissue.
    Folkerd EJ, James VH.
    J Steroid Biochem; 1982 Apr 07; 16(4):539-43. PubMed ID: 6953289
    [Abstract] [Full Text] [Related]

  • 10. Dissection of the physiological interconversion of 5alpha-DHT and 3alpha-diol by rat 3alpha-HSD via transient kinetics shows that the chemical step is rate-determining: effect of mutating cofactor and substrate-binding pocket residues on catalysis.
    Heredia VV, Penning TM.
    Biochemistry; 2004 Sep 28; 43(38):12028-37. PubMed ID: 15379543
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Critical residues for the specificity of cofactors and substrates in human estrogenic 17beta-hydroxysteroid dehydrogenase 1: variants designed from the three-dimensional structure of the enzyme.
    Huang YW, Pineau I, Chang HJ, Azzi A, Bellemare V, Laberge S, Lin SX.
    Mol Endocrinol; 2001 Nov 28; 15(11):2010-20. PubMed ID: 11682630
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Polycyclic aromatic hydrocarbon quinone-mediated oxidation reduction cycling catalysed by a human placental 17beta-hydroxysteroid dehydrogenase.
    Jarabak R, Harvey RG, Jarabak J.
    Arch Biochem Biophys; 1996 Mar 01; 327(1):174-80. PubMed ID: 8615688
    [Abstract] [Full Text] [Related]

  • 16. Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
    Bellavance E, Luu-The V, Poirier D.
    J Med Chem; 2009 Dec 10; 52(23):7488-502. PubMed ID: 19772289
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multiple steps determine the overall rate of the reduction of 5alpha-dihydrotestosterone catalyzed by human type 3 3alpha-hydroxysteroid dehydrogenase: implications for the elimination of androgens.
    Jin Y, Penning TM.
    Biochemistry; 2006 Oct 31; 45(43):13054-63. PubMed ID: 17059222
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical factors governing the steady-state estrone/estradiol ratios catalyzed by human 17beta-hydroxysteroid dehydrogenases types 1 and 2 in HEK-293 cells.
    Sherbet DP, Guryev OL, Papari-Zareei M, Mizrachi D, Rambally S, Akbar S, Auchus RJ.
    Endocrinology; 2009 Sep 31; 150(9):4154-62. PubMed ID: 19556422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.